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IntroductIon
Zinc metallopeptidase STE24 (ZMP STE24) is a seven-spanner 
transmembrane-associated zinc metalloprotease. ZMP STE24 
homologues are found in many taxa, including bacteria, 
higher plants, and vertebrates. ZMP STE24 enzymatic activity 
is also conserved, as indicated by the ability of human ZMP 
STE24 to complement enzymatic function of its counterpart 
in yeast (Leung et al., 2001; Ast et al., 2016). Functional com-
plementation is supported by the nearly superimposable crys-
tal structures of the yeast and human homologues (Pryor et al., 
2013; Quigley et al., 2013). Mutations in the zmpste24 gene 
that result in decreased enzyme function lead to a spectrum 
of diseases that share certain features of Hutchinson–Gilford 
progeria syndrome, including premature aging (Pegoraro et 
al., 2009; Young et al., 2014). Disease severity correlates with 
the residual enzymatic activity of mutant ZMP STE24 (Bar-
rowman et al., 2012). Zmpste24-deficient mice also develop a 
progeroid phenotype (Bergo et al., 2002; Pendás et al., 2002).
ZMP STE24 is constitutively expressed and localizes to 
the inner nuclear membrane and cytoplasmic organelles. In 
mammals, ZMP STE24 endoprotease activity is required for 
biogenesis of lamin A, which helps maintain the structural 
integrity of nuclear membranes (Bergo et al., 2002; Pendás et 
al., 2002; Michaelis and Barrowman, 2012). Additional stud-
ies demonstrated ZMP STE24 catalytic activity removes mis-
folded proteins from clogged translocons. ZMP STE24 and 
its yeast homologue were shown to protect the translocon by 
cleaving obtruding proteins, thereby maintaining homeostasis 
of the endoplasmic reticulum (Ast et al., 2016). ZMP STE24 
has promiscuous substrate specificity cleaving a heteroge-
neous spectrum of prenylated and nonprenylated targets (Ast 
et al., 2016; Hildebrandt et al., 2016).
Many enveloped viruses are ferried deep into the cy-
toplasm through endocytic vesicles and use the low pH 
endosomal environment to activate viral fusion proteins 
(Cossart and Helenius, 2014). Higher vertebrates evolved 
interferon-induced transmembrane protein (IFI TM) family 
proteins to hinder endosomal penetration by fusogenic vi-
ruses (Brass et al., 2009; Perreira et al., 2013; Bailey et al., 
2014). We now report the antiviral properties of IFI TM 
are dependent on ZMP STE24.
results and dIscussIon
ZMP ste24 restricts viral infection, independent 
of its protease activity
HEK293 cells stably expressing C-terminal FLAG-tagged 
IFI TM3 were stimulated with interferon. Affinity purifi-
cation coupled with mass spectrometry (AP-MS) identi-
fied IFI TM3-associated proteins. The significance analysis 
of interactome (SAI NT) algorithm was adopted to analyze 
AP-MS data in combination with our reference database of 
FLAG-tagged protein complexes purified under identical 
conditions (Fu et al., 2015). 10 high-confidence interacting 
proteins including ZMP STE24 with SAI NT scores >0.89 
were identified (Table S1).
Zinc metallopeptidase ste24 (ZMP ste24) is a transmembrane metalloprotease whose catalytic activity is critical for process-
ing lamin a on the inner nuclear membrane and clearing clogged translocons on the endoplasmic reticulum. We now report 
ZMP ste24 is a virus-specific effector that restricts enveloped rna and dna viruses, including influenza a, Zika, ebola, sindbis, 
vesicular stomatitis, cowpox, and vaccinia, but not murine leukemia or adenovirus. ZMP ste24-mediated antiviral action is 
independent of protease activity. coimmunoprecipitation studies indicate ZMP ste24 can complex with proteins of the interferon- 
induced transmembrane protein (IFI tM) family. IFI tM proteins impede viral entry, and ZMP ste24 expression is necessary for 
IFI tM antiviral activity. In vivo studies demonstrate ZMP ste24-deficient mice display higher viral burdens, enhanced 
cytokine production, and increased mortality after influenza infection. collectively, these findings identify ZMP ste24 as an 
intrinsic broad-spectrum antiviral protein and provide insights into antiviral defense mechanisms.
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Coimmunoprecipitation studies examined interactions 
between ZMP STE24 and IFI TM family proteins. ZMP 
STE24 specifically binds IFI TM1, IFI TM2, or IFI TM3 
(Fig. 1 A). In contrast to IFI TM, ZMP STE24 transcription 
is not up-regulated by IFNβ stimulation (Fig. 1 B). To inves-
tigate the antiviral function of ZMP STE24, HEK293 cells 
were transiently transfected with FLAG-tagged or control 
untagged ZMP STE24 24 h before infection with influenza 
A/Puerto Rico/8/1934 virus (PR8) with Gaussia lucifer-
ase (GLuc; PR8-GLuc) reporter virus (Heaton et al., 2013). 
Both constructs inhibited influenza A virus (IAV) reporter 
activity (Fig.  1  C). Next, A549 lung cells were transfected 
with ZMP STE24-FLAG; after 2 d, the cells were infected 
with PR8 IAV and examined by immunofluorescence. Ec-
topic expression of ZMP STE24 limits and delays viral in-
fection (Fig. 1 D). Furthermore, A549 cells expressing ZMP 
STE24 produce fewer infectious IAV particles, as measured 
by plaque assay (Fig. 1 E).
To investigate viral specificity, ZMP STE24 trans-
fected cells were infected with vesicular stomatitis virus 
(VSV) carrying a firefly luciferase (Luc) gene (VSV-Luc; 
Cureton et al., 2012). ZMP STE24 strongly inhibited 
VSV reporter activity (Fig. 1 F). Thus, the effect of ZMP 
STE24 overexpression was tested on additional RNA vi-
ruses (Sindbis, murine leukemia virus [MLV], and Zika). 
ZMP STE24 also inhibited Sindbis reporter activity, but 
not MLV (Fig. 1 F). Ectopic ZMP STE24 expression also 
inhibits Zika infection in human T98-G glioblastoma 
cells (Fig.  1  G). Next, we examined the ability of ZMP 
STE24 to restrict infection with three DNA viruses: ade-
novirus (AdV), vaccinia virus (VACV), and cowpox virus. 
Overexpression of ZMP STE24 inhibited infection with 
VACV and cowpox virus, but not AdV (Fig. 1 F). As the 
IFI TM sensitivity of pox viruses was not previously re-
ported, we compared the ability of these viruses to infect 
ifitmDel−/− (deletion of ifitm1, 2, 3, 5, and 6) and recon-
stituted cells. The data indicate IFI TM selectively protects 
against pox virus infection (Fig. 1 H).
To corroborate the role of ZMP STE24 in antiviral 
defense, zmpste24−/− MEFs were examined. Plaque assays 
establish increased IAV production by zmpste24−/− cells 
(Fig. 2 A). To evaluate antiviral specificity, zmpste24−/− and 
zmpste24+/+ MEFs were infected with VSV, Sindbis, MLV, 
VACV, cowpox, and AdV. Deficiency of ZMP STE24 en-
hanced VSV, Sindbis, cowpox, and VACV reporter activity, 
but not MLV and AdV (Fig.  2 B). Importantly, reconsti-
tution of zmpste24−/− MEFs with human ZMS PTE24 
restored antiviral activity (Fig. 2 C). ZMP STE24 knock-
down also enhanced Zika virus replication in T98-G glio-
blastoma cells (Fig. 2 D). Finally, we examined the effects 
of ZMP STE24 deficiency on primary human tracheal 
cells. RNAi depletion of ZMP STE24 increased IAV, VSV, 
Sindbis, cowpox, and VACV infection in primary human 
respiratory epithelial cells (Fig.  2  E). To exclude RNAi 
off-target effects, cells were transfected with an siRNA- 
resistant ZMP STE24 rescue construct before infection 
with PR8 reporter virus. The rescue construct restored an-
tiviral activity, validating siRNA specificity (Fig. 2 F). The 
combined data suggest ZMP STE24 restricts infection by 
selected RNA and DNA viruses.
To ascertain if enzymatic activity is critical for viral re-
striction, we mutated residues within the conserved HEX XH 
zinc metalloprotease motif, which is essential for catalytic ac-
tivity (Pryor et al., 2013; Quigley et al., 2013). Wild type and 
mutants H335A and E336A exhibited comparable protection 
against IAV infection in A549 cells (Fig.  3 A). In addition, 
various ZMP STE24 mutations identified from patients with 
reduced enzymatic activity (Barrowman et al., 2012) also dis-
played antiviral activity, with the exception of the L94P muta-
tion, which lacked protein expression (Fig. 3 A). Furthermore, 
zmpste24−/− MEFs reconstituted with human ZMP STE24 
or the E336A catalytically inactive mutant restored host re-
striction to IAV, VSV, and VACV (Fig. 3 B). Collectively, the 
combined data suggest protease activity is not essential for 
ZMP STE24 antiviral function.
ZMP ste24 cooperates with IFI tM to inhibit viral entry
Most enveloped viruses enter cells by breaching endosomal 
membrane barriers. To investigate the role of ZMP STE24 
in viral entry, we examined the effects of ZMP STE24 over-
expression on IAV release from endosomes. ZMP STE24 
restrained IAV release from highly acidic LysoTracker 
red–positive vesicles in A549 cells (Fig. 3 C). Furthermore, 
direct viral fusion assays using virus-like particles (VLPs) 
demonstrate zmpste24−/− cells are more susceptible to IAV 
viral entry than zmpste24+/+ cells (Fig. 3 D). In contrast, 
ZMP STE24 expression has no effect on entry of MLV 
particles (Fig. 3 D). Zmpste24−/− cells also demonstrated 
increased susceptibility to infection with VLP contain-
ing glycoproteins from HA1, HA5, or HA7 IAV, VSV, 
and Ebola (Fig.  3  E). Reciprocally, ZMP STE24 over-
expression inhibited entry of IAV, VSV, and Ebola VLP 
(Fig. 3 F). Collectively, the data suggest ZMP STE24 im-
pedes viral endosomal entry.
To establish the functional relationship between ZMP 
STE24 and IFI TM3, we performed genetic complementation 
experiments. Ectopic expression of IFI TM3 does not restore 
antiviral function in zmpste24−/− cells (Fig. 3 B). However, 
ectopically expressed ZMP STE24 restores antiviral activity 
against IAV, VSV, and VACV in ifitmDel−/− cells (Fig. 3 G). 
To determine whether ZMP STE24 can still exert antiviral 
activity in the absence of IFI TM, we silenced ZMP STE24 
in ifitmDel −/− MEFs. Notably, ZMP STE24 knockdown un-
covers an IFI TM-independent restriction on VSV and VACV 
infection (Fig. 3 H). The combined results imply ZMP STE24 
is required for IFI TM antiviral action, although the need 
for IFI TM can be bypassed. The data are compatible with a 
model in which ZMP STE24 serves as a downstream effec-
tor in the IFI TM pathway, although an IFI TM-independent 
pathway also exists.
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Figure 1. ZMP ste24 protects against viral infection. (A) ZMP STE24-FLAG was transfected with HA-tagged STI NG, IFI TM1, IFI TM2, or IFI TM3 into 
HEK293 cells. After 48 h, cells were lysed and immunoprecipitated with anti-HA antibody and blotted with the indicated antibodies. Data are representative 
of two independent experiments. Molecular mass is indicated in kilodaltons. IP, immunoprecipitation; WB, Western blot. (B) A549 cells were stimulated with 
5 U IFNβ for the designated times. IFI TM1, IFI TM2, IFI TM3, ZMP STE24, and control GAP DH mRNA levels were examined by real-time PCR (three independent 
experiments). Mean ± SD; *, P < 0.05. (C) Empty vector, ZMP STE24-FLAG, or untagged ZMP STE24 were transfected into HEK293 cells. After 24 h, cells were 
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ZMP ste24 is required for influenza restriction in vivo
The progeria phenotype of zmpste24−/− mice can be com-
plemented by reducing the level of prelamin A. Zmpste24−/− 
mice with half-normal levels of prelamin A are protected 
from disease (Fong et al., 2004, 2006; Varela et al., 2005; 
Mariño et al., 2008) and mount normal primary antibody 
responses after immunization with a limiting dose of IAV- 
derived HA protein (Fig.  4  A). To define the in vivo role 
of ZMP STE24 on viral restriction, we compared antiviral 
responses of lmna+/−zmpste24−/−, lmna+/−zmpste24+/−, and 
lmna+/−zmpste24+/+ animals. ZMP STE24-deficient mice 
displayed increased susceptibility to IAV with signs of se-
vere clinical illness, including lethargy, hunched posture, and 
accelerated weight loss (Fig. 4 B). The weight loss in zmp-
ste24 heterozygous mice was intermediate, suggesting a gene 
dose effect (Fig. 4 B). 65% of zmpste24−/− animals became 
moribund (defined as 25% loss of body mass) compared 
with 20% and 0% in other groups (Fig. 4 C). IAV was de-
tected in the lungs of all infected animals but did not spread 
to the spleen (Fig. 4 D). Lungs from ZMP STE24-deficient 
mice exhibit the greatest increase in viral load. A gene dose 
effect was noted in the zmpste24+/− group (Fig. 4 D). Two 
days after infection, lungs from IAV-infected ZMP STE24- 
deficient animals displayed focal areas of vasculitis and bron-
chitis with mixed polynuclear/mononuclear infiltrates and 
scattered areas of epithelial necrosis, whereas less pathol-
ogy was noted in controls (Fig. 4 E). The histological find-
ings were supported by increased levels of cytokines (IFNβ, 
TNF, and IL-6) and chemokines (MCP1/CCL2 and KC/
CXCL1) in the lungs of IAV-infected zmpste24−/− animals 
(Fig. 4 F). After IAV infection, pulmonary IFI TM3 expression 
was enhanced in zmpste24−/− and control mice. In contrast, 
ZMP STE24 mRNA remained at constitutive levels after 
IAV infection (Fig. 4 G). The findings indicate ZMP STE24 
expression is not regulated by viral infection. The combined 
data suggest ZMP STE24 deficiency is associated with en-
hanced viral proliferation and correspondingly more exten-
sive tissue damage and imply ZMP STE24-deficient mice are 
unable to control influenza infection.
In summary, ZMP STE24 is an intrinsic antiviral protein 
that protects against pathogen attack. Of nine tested viruses, 
ZMP STE24 selectively restricted infection by six distinct vi-
ridae families, representing diverse groups of enveloped RNA 
and DNA viruses. All ZMP STE24-sensitive viruses require 
access to acidic endosomal compartments for viral entry. 
Representatives of each architectural class of fusogenic viral 
glycoprotein (Harrison, 2015) are susceptible to ZMP STE24 
inhibition, suggesting a common mechanism that alters en-
dosomal trafficking or membrane structure rather than direct 
interaction with this varied assortment of virally encoded fu-
sion proteins. Although we cannot exclude the possibility that 
ZMP STE24 or IFI TM associate with a common host-de-
rived membrane element present in the viral envelop.
The best-characterized host restriction proteins in-
volved in regulating viral entry are members of the IFI TM 
family. ZMP STE24 is detected in IFI TM protein complexes 
and restricts a similar spectrum of RNA and DNA viruses. 
Genetic complementation experiments indicate ZMP STE24 
is required for IFI TM antiviral activity, placing these two 
transmembrane proteins in a common pathway.
Viral endocytic entry is a complex process, involving 
endosomal trafficking, endosomal maturation, membrane 
bending, fluidity of membrane lipids, pre-hemifusion, and 
post-hemifusion events. Host proteins may interfere with dif-
ferent steps of the viral endocytic entry process. At the cur-
rent stage, it is not clear which steps involve ZMP STE24, 
how ZMP STE24 antiviral activity is regulated, or whether 
other cofactors interact with ZMP STE24. Nonetheless, 
ZMP STE24 is an important element for innate host defense 
against a broad spectrum of pathogenic viruses.
MaterIals and Methods
Mouse infection
Zmpste24+/− and lmna+/− animals on a C57BL background 
(N3 and N9, respectively) were purchased from Mutant Mouse 
Resource and Research Centers and The Jackson Laboratory, 
respectively. Intercrossed mice were maintained under spe-
cific pathogen–free conditions before infection. To avoid the 
complications of progeria, all experimental mice were hetero-
zygous for the lmna gene (Fong et al., 2004, 2006; Varela et 
al., 2005; Mariño et al., 2008). Cohorts of age matched (2–4 
mo) mice were anesthetized with 100 µg/g ketamine: 5 µg/g 
xylazine and then inoculated intranasally with 200 pfu influ-
enza A/PR/8/34 in 20 µl sterile PBS. Weights were recorded 
daily as well as monitoring for signs of illness. Mice with 25% 
weight loss were considered moribund and euthanized. For 
histopathology, lungs from infected mice were fixed in Bouin 
solution (3 d) or 10% formalin (24 h) before transfer to 70% 
ethanol. Specimens were paraffin-embedded and stained by 
the Dana Farber/Harvard Cancer Center Histopathology 
infected with 0.1 MOI PR8-GLuc for 16 h. Cell viability was determined by CellTiter-Glo, which was used for normalization (three experiments). Mean ± SD; 
*, P < 0.05. (D) A549 cells transfected with ZMP STE24-FLAG (48 h) and then infected with 1 MOI PR8 for the indicated times (two experiments; percentage 
of positive cells from five fields ± SD are denoted). Bars, 100 µm. (E) A549 cells transfected with ZMP STE24-FLAG were infected with 0.001 MOI WSN IAV 
for 12 h. Virus titers were determined by plaque assay. Data are representative of three experiments. Mean ± SD; *, P < 0.05. (F) A549 cells transfected with 
ZMP STE24-FLAG were infected with 1 MOI IAV-GLuc, VSV-Luc, Sindbis-Luc, MLV-Luc, VACV-Luc, cowpox-Luc, and AdV5-Luc for 16 h (consolidated data). 
Each group was analyzed three times. Mean ± SD; *, P < 0.05. Viability assays of infected cells indicate <20% differences among groups. (G) GFP-FLAG or 
ZMP STE24-FLAG was transfected in T98-G cells for 24 h before infection with 0.01 MOI MR 766 Zika virus. After 72 h, Zika virus titers were determined by 
plaque assay (three experiments). Mean ± SD; *, P < 0.05. (H) Wild-type, ifitmDel−/−, and reconstituted MEFs were infected with 1 MOI AdV, VACV-Luc, or 
cowpox-Luc for 16 h. Relative luciferase activities were examined (three experiments). Mean ± SD; *, P < 0.05.
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core services. All experiments were performed with approval 
of Harvard Medical School, Committee on Animals.
Immunization
Animals were immunized s.c. in two sites with a total of 
10 µg purified PR8-derived HA antigen (Sino Biolog-
icals) precipitated with 2 mg magnesium hydroxide and 
2 mg aluminum hydroxide.
antibodies
Source, application, and dosage are indicated sequentially as 
follows: anti–β-actin (WB [1:1000]; Abcam), anti-FLAG (WB 
[1:1,000]; Sigma-Aldrich), anti-NP (IFA [1:1,000]; EMD 
Millipore), anti-HA epitope (WB [1:1,000]; Sigma-Aldrich), 
monoclonal anti-ZMP STE24 antibody (described elsewhere; 
Pendás et al., 2002; WB [1:500]; gift from C. López-Otin, 
University of Oviedo, Oviedo, Spain), goat anti–rabbit IgG-
HRP (WB [1:10,000]; Santa Cruz Biotechnology, Inc.), and 
Alexa Fluor 488 or 594 goat anti–mouse IgG (H+L, IFA 
[1:200]; Thermo Fisher Scientific).
Plasmids
Human ZMP STE24, IFI TM1, IFI TM2, and IFI TM3 cDNA 
were provided by the Dana Farber/Harvard Cancer Center 
DNA Resource Core. C-terminal epitope-tagged constructs 
were made by cloning into pCMV-3Tag-8 (Agilent Technol-
ogies). Mutations of ZMP STE24-FLAG were constructed 
using the QuikChange II Site-Directed Mutagenesis kit 
Figure 2. ZMP ste24 deficiency increases susceptibility to viral infection. (A) Zmpste24+/+ or zmpste24−/− MEFs were infected with 0.001 MOI WSN 
IAV for 12 h. Viral titers were determined by plaque assay (three experiments). Mean ± SD; *, P < 0.05. (B) Zmpste24+/+ or zmpste24−/− MEFs infected with 
1 MOI IAV-GLuc, VSV-Luc, Sindbis-Luc, MLV-Luc, VACV-Luc, cowpox-Luc, and AdV-Luc for 16 h (consolidated data). Each group was analyzed in three 
experiments. Mean ± SD; *, P < 0.05. Viability comparisons indicate <20% differences between control and ZMP STE24-deficient groups. (C) Zmpste24+/+, 
zmpste24−/−, and zmpste24−/− MEFs expressing human ZMP STE24 were infected with IAV-GLuc, VSV-Luc, and VACV-Luc for 16 h. Data from one of three 
experiments are shown. Mean ± SD; *, P < 0.05. (D) Control or ZMP STE24 siRNA#1 were transfected in T98-G cells for 24 h before infection with 0.01 MOI 
MR 766 Zika virus. After 72 h, Zika virus titers were determined by plaque assay (three experiments). Mean ± SD; *, P < 0.05. (E) Primary human tracheal 
epithelial cells were transfected with ZMP STE24 siRNAs (72 h) and then infected with the indicated luciferase-expressing viruses for 16 h. Data are from 
one of three experiments performed in triplicate. Mean ± SD; *, P < 0.05. Right panel depicts siRNA knockdown efficiency. (F) A549 cells were transfected 
with GFP-FLAG, ZMP STE24-FLAG, rescue ZMP STE24-FLAG, and control or ZMP STE24 siRNA#1. After 48 h, cells were infected with 0.01 MOI PR8-GLuc for 
16 h. The relative luciferase signal is shown. Western blot demonstrates expression levels. Data are from one of three experiments performed in triplicate. 
Mean ± SD; *, P < 0.05. (E and F) Molecular mass (MM) is indicated in kilodaltons.
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Figure 3. ZMP ste24 inhibits viral entry, but catalytic activity is dispensable for antiviral function. (A) HEK293 cells were transfected with vec-
tor, ZMP STE24-FLAG, or the indicated ZMP STE24 mutants. After 24 h, cells were infected with 1 MOI PR8-GLuc for 16 h. Luciferase activity assays were 
performed. Each group was tested in three experiments. Mean ± SD; *, P < 0.05. (B) Zmpste24+/+, zmpste24−/−, and zmpste24−/− MEFs transduced with 
retrovirus expressing FLAG-tagged GFP, ZMP STE24, E336A mutant ZMP STE24, or IFI TM3-HA were infected with IAV-GLuc, VSV-Luc, or VACV-Luc for 16 h. 
Relative luciferase levels are shown. Representative data from one of three experiments are shown. Mean ± SD; *, P < 0.05. Western blot demonstrates 
expression levels. (C) A549 cells transfected with ZMP STE24 were infected with 50 MOI PR8 (2 h) and then stained with LysoTracker red, DAPI, and anti-NP. 
The arrowhead indicates nuclear localization of influenza NP protein. Arrows indicate representative colocalized puncta. Pearson’s r coefficients are denoted. 
Bars, 10 µm. (D) Zmpste24+/+ and zmpste24−/− cells were infected with IAV or MLV VLPs and then loaded with CCF2. Cleavage of CCF2 was determined by 
fluorescence emission shift from 520 nm (uncleaved CCF2) to 447 nm (cleaved CCF2). Data are representative of two experiments. (E) Zmpste24+/+ and 
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(Agilent Technologies). For retroviral infection, ZMP STE24-
FLAG and IFI TM3 were cloned into pQCX IP retroviral vec-
tor (Takara Bio Inc.). HEK293 cells were transfected using 
Lipofectamine 2000 Transfection Reagent, whereas A549 
cells were transfected using Lipofectamine LTX Transfection 
Reagent (Thermo Fisher Scientific) according to the man-
ufacturer’s protocol. After 48 h, cells were ready for further 
treatment. IFI TM3-HA and STI NG-HA constructs (Ishi-
kawa and Barber, 2008; Brass et al., 2009) were gifts from 
A. Brass (University of Massachusetts Medical School, 
Worcester, MA) and G. Barber (University of Miami School 
of Medicine, Miami, FL), respectively.
cells
HEK293 cells (ATCC), ifitmDel−/− MEFs (Brass et al., 2009; 
a gift from M. Farzan, Scripps Research Institute, Jupiter, 
FL), zmpste24+/+ MEFs, and zmpste24−/− MEFs (Bergo et 
al., 2002; a gift from S. Young, University of California, San 
Francisco, San Francisco, CA) were maintained in DMEM 
containing antibiotics and 10% FBS. A549 and T98-G cells 
(ATCC) were cultured in RPMI Medium 1640 plus 10% 
FBS and 1× MEM nonessential amino acids solution. Pri-
mary human tracheal epithelial cells and supporting medium 
were purchased from Lifeline Technology.
Viruses
Influenza PR8-GLuc virus with a GLuc gene inserted down-
stream of PB2 was a gift from P. Palese (Mount Sinai School 
of Medicine, New York, NY; Heaton et al., 2013). IAV was 
propagated in specific pathogen-free fertilized eggs Premium 
Plus (Charles River) according to previously published proto-
cols (Szretter et al., 2006). IAV was titered by plaque assay as 
described elsewhere (Matrosovich et al., 2006).
VSV-Luc was a gift from S. Whelan (Harvard Medical 
School, Boston, MA). VACV with Luc gene (VACV-Luc) 
was a gift from D.L. Bartlett (University of Pittsburg, Pitts-
burg, PA). Cowpox virus expressing luciferase was a gift from 
B. Moss (National Institutes of Health, Bethesda, MD). Sind-
bis virus carrying luciferase gene was a gift from R. Andino 
(University of California, San Francisco, San Francisco, CA) 
and J. Kagan (Children’s Hospital, Boston, MA). VSV-Luc and 
VACV-Luc were expanded in BHK-21 cells. Adenovirus 5 
with luciferase was purchased from the University of Iowa 
Viral Vector Core. Zika virus MR 766 was supplied by BEI 
Resources. For Zika plaque assays, Vero cells (ATCC) were 
grown to 90% confluence and then incubated with viral sam-
ples for 1 h at 37°C. Afterward, virus was removed and cells 
were washed with PBS. The cells were then covered with 2% 
methyl-cellulose in DMEM containing 2% FBS for 6 d and 
stained with crystal violet.
reporter assay
For reporter virus assay, cells were counted using Countess 
Automated Cell Counter (Invitrogen), and equal numbers 
of cells were split into culture plates. 16 h later, cells were 
infected with indicated reporter virus for 16  h and then 
collected for reporter assay. Gaussia (New England BioLabs, 
Inc.) and Luc (dual-luciferase reporter assay; Promega) sub-
strates were used as recommended by manufacturer. Each 
experiment was performed in triplicate. P-values were de-
termined with paired Student’s two-tailed t test. Cell num-
ber was assessed using the CellTiter-Glo Luminescent Cell 
Viability Assay (Promega).
Pseudotyped virus
For viral infection activity assay, pseudotyped viruses were 
generated by coexpression of indicated viral envelope con-
struct and MSCV IRES luciferase (Addgene; donated by 
S. Lowe, Cold Spring Harbor, NY) in HEK293 cells. MSCV 
IRES luciferase plasmid was cotransfected with pCL-Ampho 
Retrovirus Packaging Vector (IMG ENEX) into HEK293 
cells to generate MLV-Luc pseudoviruses.
entry assay using VlPs
The entry assay was based on a previously published protocol 
(Tscherne and García-Sastre, 2011) with minor modifications 
as follows. To prepare IAV VLPs, HEK 293 cells were trans-
fected with β-lactamase M1 (BlaM1; β-lactamase was fused 
to WSN/33 M1 gene, a gift from A. Garcia-Sastre, Mount 
Sinai School of Medicine, New York, NY) and WSN/33 NA 
plus WSN/33 HA, or VN/2004 H5N1-HA or Anhui/2013 
H7N9-HA. To make VLPs for VSV, HEK293 cells were trans-
fected with BlaM1 and VSV-G. For preparation of the Zaire 
Ebola virus VLPs, BlaM-VP40 and Ebola glycoprotein (gifts 
from L. Rong, University of Illinois, Chicago, IL) were trans-
fected into HEK293 cells. Medium containing influenza 
VLPs was treated with 2 µg/ml TPCK-trypsin for 30 min at 
37°C to cleave HA. For preparation of MLV particles, MLV 
envelop (pHCMV-EcoEnv; Addgene) was cotransfected with 
BlaM-VP40 in HEK293 cells.
zmpste24−/− cells were infected with IAV (HA1, HA5, and HA7), VSV, and Ebola VLP (2 h) and then assayed for viral entry with CCF2. Data are representative of 
two or more experiments per group. Mean ± SD; *, P < 0.05. Percentages of positive zmpste24+/+ MEFs were 5.2%, 3.8%, 3.4%, 5.6%, and 4.2%, respectively. 
(F) HEK293 cells were transfected with ZMP STE24 for 24 h and then infected with the indicated VLPs. Data are representative of two or more experiments 
per group. Mean ± SD; *, P < 0.05. Percentages of infected cells in the vector transfected control group were 23%, 17%, 18%, 39%, and 26%, respectively. 
(G) IfitmDel−/− and ifitmDel−/− MEFs expressing GFP-FLAG, ZMP STE24-FLAG, or IFI TM3-HA were infected with 1 MOI PR8-GLuc, VSV-Luc, or VACV-Luc (16 h). 
Mean ± SD; *, P < 0.05. Western blot (WB) shows expression levels. Data are representative of two independent experiments. (A, B, and G) Molecular mass 
(MM) is indicated in kilodaltons. (H) IfitmDel−/− and wild-type MEFs were transfected with nontargeting control or ZMP STE24 siRNA#2. After 48 h, cultures 
were infected with VSV-Luc or VACV-Luc reporter virus. Luciferase levels were monitored 16 h after infection (three experiments). Mean ± SD; *, P < 0.05.
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For fusion assays, HEK293 cells were seeded into 24-
well plates and transfected with pCMV-Tag-4 vector or 
ZMP STE24-FLAG. To infect zmpste24+/+ and zmpste24−/− 
MEFs, cells were split into six-well plates and cultured in 
Opti-MEM. VLPs were added, and then plates were cen-
trifuged for 60 min at 450  g, 4°C, followed by 2–4 h in-
cubation at 37°C. To detect β-lactamase activity by flow 
cytometry, cells were detached with 0.1% trypsin/EDTA. 
Samples were gated on live cells for 10,000 events and an-
alyzed for the emission of uncleaved CCF2 at 520 nm and 
cleaved CCF2 at 447 nm.
Immunoprecipitation
1 × 106 cells were lysed in 500 µl TAP lysis buffer (50 mM 
Tris-HCl [pH 7.5], 10 mM MgCl2, 100 mM NaCl, 0.5% 
Nonidet P40, 10% glycerol, and Complete EDTA-free pro-
tease inhibitor cocktail tablets [Roche]) for 30 min at 4°C. 
Protein samples were heated at 60°C for 10 min. For im-
Figure 4. ZMP ste24 limits influenza infection in vivo. (A) Primary antibody responses of lmna+/−zmpste24+/+, lmna+/−zmpste24+/−, and lmna+/−zmpste24−/− 
mice (six animals per group) 13 d after immunization with purified PR8 HA protein. ELI SA assay; OD of all preimmune sera were below the dashed line. 
(B) Percentage of loss in body mass ± SD of lmna+/−zmpste24+/+, lmna+/− zmpste24+/−, and lmna+/−zmpste24−/− mice after i.n. infection with 200 pfu PR8 IAV. 
Groups contained 5, 15, and 17 mice, respectively. Means are indicated by horizontal bars. *, P < 0.001 versus the zmpste24−/− group by Wilcoxon rank sum 
test; P < 0.001 for zmpste24+/+ versus the zmpste24+/− group. (C) Survival curve of IAV-infected mice depicted in B. *, P < 0.05 versus lmna+/−zmpste24−/− 
group by Mantel–Cox log-rank test. (D) Comparison of pulmonary and splenic IAV (NP) levels in uninfected and infected (2 or 4 d) lmna+/−zmpste24+/+, 
lmna+/−zmpste24+/−, and lmna+/−zmpste24−/− animals (three to five mice per group) by quantitative PCR. Means ± SD are indicated by horizontal bars; 
*, P < 0.05. (E) Lung histopathology comparing lmna+/−zmpste24+/− and lmna+/−zmpste24−/− donors (2 d after IAV infection). Data are representative of 
three mice per group. Arrows point to regions of vasculitis with lymphocyte infiltrate. The asterisk illustrates region of suppurative bronchitis. Bars, 200 µm. 
(F) Relative increase in pulmonary RNA levels ± SD for cytokines (IL-6, TNF, and IFNβ) and chemokines (MCP1 and KC) in IAV-infected (day 2) mice (three 
to five animals per group) from D. Normalized to day 0 levels, the L32 housekeeping gene was used to establish comparable levels of RNA in all groups. 
*, P < 0.05. (G) IFI TM3 and ZMP STE24 mRNA expression in IAV-infected (day 2) lungs from D. Normalized to day 0 levels, the L32 housekeeping gene was 
used to normalize RNA levels. Mean ± SD; *, P < 0.05. NA indicates not applicable.
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munoprecipitation, 2% of cell lysates (106 cells) were saved 
for input control, and the remainder was incubated with 
10 µl EZview Red Anti-HA Affinity Gel (Sigma-Aldrich). 
After mixing end-over-end at 4°C overnight, the beads 
were washed three times (1 min per wash) with 500  µl 
lysis buffer. Anti-HA Affinity Gel was eluted with 50 µl of 
1 mg/ml HA peptide (Sigma-Aldrich). AP-MS procedures 
and analyses are detailed elsewhere (Fu et al., 2015). Meth-
ods for AP-MS were described previously (Fu et al., 2015). 
SAI NT scores were calculated following established proce-
dures (Choi et al., 2011).
Immunofluorescence assay
Cells were cultured in the Lab-Tek II Chamber Slide with 
Cover CC2 Glass Slide Sterile (4 wells; Thermo Fisher 
Scientific). After indicated treatment, cells were fixed and 
permeabilized using cold methanol for 10 min at −20°C. 
The slides were then washed with PBS for 10 min and 
blocked with Odyssey Blocking Buffer (LI-COR Biosci-
ences) for 1 h. Slides were incubated in Odyssey Blocking 
Buffer with appropriately diluted primary antibodies at 4°C 
for 16 h. After three washes (5 min per wash) with PBS, cells 
were incubated with corresponding Alexa Fluor–conjugated 
secondary antibodies (Thermo Fisher Scientific) for 1 h at 
room temperature. The slides were washed three times (5 
min each time) with PBS and counter stained with 300 nM 
DAPI for 1 min, followed by PBS washing for 1 min. After 
air drying, slides were sealed with Gold Seal Cover Glass 
(Electron Microscopy Sciences) using Fluorogel (Electron 
Microscopy Sciences). Images were captured and analyzed 
using a FluoView confocal microscope (Olympus). At least 
20 cells were analyzed in each experiment, and representa-
tive data from three experiments are presented.
real-time Pcr
Lungs and spleens were collected in 1 ml RNAlater (Am-
bion) and stored at −80°C. Specimens were homogenized 
using the TissueLyser II apparatus (QIA GEN). Total RNA 
was prepared using RNeasy columns (QIA GEN), after which 
the RNA was treated with RNase-free DNase to remove 
contaminating DNA. 1 µg RNA was transcribed into cDNA 
using QuantiTect reverse transcription kit (QIA GEN). For 
one real-time reaction, a 20 µl SYBR green PCR reaction 
mix (Roche) including 1/10 of the synthesized cDNA plus 
an appropriate oligonucleotide primer pair was run on the 
LightCycler 480 (Roche). The comparative Ct method was 
used to determine relative mRNA expression of genes as 
normalized by the housekeeping genes, GAP DH or L32. 
Primer sequences are listed in Table 1.
rnai depletion
RNAi duplexes for human ZMP STE24 (s20065 and 
s20066; Ambion) and mouse ZMP STE24 (s20066; Ambion) 
were verified by RT-PCR. A549 and MEFs were trans-
fected with siRNA duplexes using Lipofectamine RNAi-
MAX Transfection Reagent (Thermo Fisher Scientific) 
according to the manufacturer’s protocol. Knockdown was 
allowed to proceed for 48 h before cells were infected or 
tested in functional assays.
elI sa
50 µl of 1 µg/ml PR8-derived HA antigen in borate buffer, 
pH 8.5, was coated onto 96-well MaxiSorp Immuno plates 
(Nalgene Nunc) overnight and then blocked with PBS con-
taining 1% BSA and 0.05% Tween 20. 100 µl antisera diluted 
1:50 in blocking buffer was added to each well and incubated 
for 1 h at room temperature. After three washes in PBS with 
0.05% Tween 20, HRP-conjugated anti–mouse Ig (1:1,000; 
Invitrogen) was added for 1 h. After five rinses with PBS plus 
0.05% Tween 20, 100 µl o-phenylenediamine dihydrochlo-
ride substrate solution (Sigma-Aldrich) was added for 25 min. 
The reaction was stopped with 100  µl 0.5 M H2SO4, 
and optical densities were read at 490 nm (Spectro Max 
Plus; Molecular Devices).
Table 1. Primer sequences used in this study
Target Forward primer (5′–3′) Reverse primer (5′–3′)
hZMP STE24              TGT ACC ACC GGA GTT AGG ACA                AGC CAG CAT AAC CAC AGA ACC
hIFI TM1              ATC AAC ATC CAC AGC GAG AC                CAA CCA TCT TCC TGT CCC TAG
hIFI TM2              GAT GTC CAC CGT GAT CCAC                CAA CCA TCT TCC TGT CCC TAG
hIFI TM3              CCA ACC ATC TTC CTG TCCC                ATG TCG TCT GGT CCC TGT TC
mZMP STE24              GCC TGG CTG TTC ACA TTA GTT                GGA ACG CTT AGA TCC TTC AAC AA
hGAP DH              AGG TGA AGG TCG GAG TCA                GGT CAT TGA TGG CAA CAA
mIL-6              TGG GGC TCT TCA AAA GCT CC                AGG AAC TAT CAC CGG ATC TTC AA
mIFNβ              CAG CTC CAA GAA AGG ACG AAC                GGC AGT GTA ACT CTT CTG CAT
mTNFα              TAC TGA ACT TCG GGG TGA TTG GTCC                CAG CCT TGT CCC TTG AAG AGA ACC
mKC              TGC ACC CAA ACC GAA GTC AT                TTG TCA GAA GCC AGC GTT CAC
mMCP1              ACC ACA GTC CAT GCC ATC AC                TTG AGG TGG TTG TGG AAA AG
mL32              AAG CGA AAC TGG CGG AAAC                TAA CCG ATG TTG GGC ATC AG
mIFI TM3              CCC CCA AAC TAC GAA AGA ATCA                ACC ATC TTC CGA TCC CTA GAC
Rescue              CCG ACT ACA TTG CCC CTT TAT TTG AC                CGT AAA TGG TGA CAA GAA CCA GAG AC
PR8 IAV NP              GCG TCT CAA GGC ACC AAAC                TCA AAA GCA GAG AGC ACC ATT
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statistical analysis
Unless noted otherwise, statistical significance was de-
termined by two-tailed Student’s t test for two groups. 
Analyses with a probability value <0.05 were considered 
statistically significant.
online supplemental material
Table S1, included as an Excel file, shows an AP-MS dataset.
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